Contact
searchSearch
HMP Global

April 2018 - FRMC

Department

Conference Insider
Study Examines Multiple PARP Inhibitors
05/07/2018
A featured poster session at the Society of Gynecologic Oncology’s (SGO) 2018 Annual Meeting detailed the results of a study comparing the efficacy and tolerability of PARP inhibitors as maintenance treatment in BRCA-mutated...
A featured poster session at the Society of Gynecologic Oncology’s (SGO) 2018 Annual Meeting detailed the results of a study comparing the efficacy and tolerability of PARP inhibitors as maintenance treatment in BRCA-mutated...
A featured poster session at the...
05/07/2018
First Report Managed Care
Conference Insider
The Current and Future Role of PARP Inhibitors
05/07/2018
Joyce F Liu, MD, MPH, recently discussed the current and future role of PARP inhibitors for the treatment of ovarian cancer at the Society of Gynecologic Oncology’s 2018 Annual Meeting.
Joyce F Liu, MD, MPH, recently discussed the current and future role of PARP inhibitors for the treatment of ovarian cancer at the Society of Gynecologic Oncology’s 2018 Annual Meeting.
Joyce F Liu, MD, MPH, recently...
05/07/2018
First Report Managed Care
Conference Insider
ASCO Alternative Payment Model Yields Savings in Ovarian Cancer
05/07/2018
The American Society of Clinical Oncology’s (ASCO) Patient-Centered Oncology Payment (PCOP) model helps achieve costs savings in ovarian cancer when hospitalizations are reduced during the active treatment period, according to a study...
The American Society of Clinical Oncology’s (ASCO) Patient-Centered Oncology Payment (PCOP) model helps achieve costs savings in ovarian cancer when hospitalizations are reduced during the active treatment period, according to a study...
The American Society of Clinical...
05/07/2018
First Report Managed Care
Conference Insider
Urgent TAVR Has Beneficial Outcomes Compared With Elective TAVR
05/07/2018
Recent research presented at the ACC 2018 Scientific Session found that urgent or emergent transcatheter aortic valve replacement (TAVR) has acceptable outcomes when compared with elective TAVR. 
Recent research presented at the ACC 2018 Scientific Session found that urgent or emergent transcatheter aortic valve replacement (TAVR) has acceptable outcomes when compared with elective TAVR. 
Recent research presented at the...
05/07/2018
First Report Managed Care
Conference Insider
P2Y12 Inhibitor Copayment Program Did Not Improve Outcomes for MI Patients
05/07/2018
A recent clinical trial found that while reducing copayments for myocardial infarction (MI) patients taking P2Y12 receptor inhibitors improved adherence, it did not impact clinical outcomes after 1 year.
A recent clinical trial found that while reducing copayments for myocardial infarction (MI) patients taking P2Y12 receptor inhibitors improved adherence, it did not impact clinical outcomes after 1 year.
A recent clinical trial found...
05/07/2018
First Report Managed Care
Conference Insider
SGLT-2 Inhibitors Significantly Reduced Risk for CVD in Diabetes Patients
05/07/2018
New data released at the 2018 ACC Scientific Session confirmed that use of SGLT-2 inhibitors among patients with type-2 diabetes significantly decreases risk for cardiovascular death.
New data released at the 2018 ACC Scientific Session confirmed that use of SGLT-2 inhibitors among patients with type-2 diabetes significantly decreases risk for cardiovascular death.
New data released at the 2018...
05/07/2018
First Report Managed Care
Conference Insider
Opioid Misuse Risk Management Strategies For Payers and PBMs
05/07/2018
David Calabrese, RPh, MHP, Chief Pharmacy Officer at OptumRx, discussed how payers and PBMs can mitigate the risk and impact of the current opioid crisis in the United States, during his session at the PBMI 2018 National Conference.
David Calabrese, RPh, MHP, Chief Pharmacy Officer at OptumRx, discussed how payers and PBMs can mitigate the risk and impact of the current opioid crisis in the United States, during his session at the PBMI 2018 National Conference.
David Calabrese, RPh, MHP, Chief...
05/07/2018
First Report Managed Care
Conference Insider
An Investor’s Perspective on Shifting PBM Landscape
05/07/2018
Recently at the PBMI 2018 Annual Meeting, George Hill, managing director at RBC Capital Markets, recapped some recent marketplace changes and gave his outlook on how the PBM landscape is trending.
Recently at the PBMI 2018 Annual Meeting, George Hill, managing director at RBC Capital Markets, recapped some recent marketplace changes and gave his outlook on how the PBM landscape is trending.
Recently at the PBMI 2018 Annual...
05/07/2018
First Report Managed Care
Conference Insider
General Session: Is the PBM Industry Evolving or Disrupting?
05/07/2018
During the keynote presentation at PBMI, Adam Fein, PhD, discussed the current place of PBMs in the market and how he sees this changing in the near future.
During the keynote presentation at PBMI, Adam Fein, PhD, discussed the current place of PBMs in the market and how he sees this changing in the near future.
During the keynote presentation...
05/07/2018
First Report Managed Care
Conference Insider
ICER’s President Discusses The Future of Formulary Design
05/07/2018
During PBMI 2018, Steve Pearson, MD, explained how payers can improve access to high cost drugs without sacrificing affordability.
During PBMI 2018, Steve Pearson, MD, explained how payers can improve access to high cost drugs without sacrificing affordability.
During PBMI 2018, Steve Pearson,...
05/07/2018
First Report Managed Care

Behind the Bill

Behind the Bill
SCOTUS Takes on the Nondelegation Doctrine: Surprising Reactions and What They Mean for Agency Power
04/02/2025
Katie Hayes, MJ
The Supreme Court recently heard arguments in Federal Communication Commission (FCC) v Consumers’ Research, a case that I covered in February and one that could dramatically reshape federal agency authority through the nondelegation...
The Supreme Court recently heard arguments in Federal Communication Commission (FCC) v Consumers’ Research, a case that I covered in February and one that could dramatically reshape federal agency authority through the nondelegation...
The Supreme Court recently heard...
04/02/2025
First Report Managed Care
Behind the Bill
Dr Oz’s Prescription for Making Medicaid “Viable at Every Level”
03/26/2025
Katie Hayes, MJ
On Tuesday, March 25, 2025, the Senate Finance Committee voted to advance Dr Mehmet Oz in his confirmation as the next head of the Centers for Medicare and Medicaid Services (CMS).1 The full Senate vote is expected “soon” (whatever that...
On Tuesday, March 25, 2025, the Senate Finance Committee voted to advance Dr Mehmet Oz in his confirmation as the next head of the Centers for Medicare and Medicaid Services (CMS).1 The full Senate vote is expected “soon” (whatever that...
On Tuesday, March 25, 2025, the...
03/26/2025
First Report Managed Care
Behind the Bill
The $880 Billion Question Continues: Dr Oz's Confirmation and the Future of Medicaid
03/19/2025
Katie Hayes, MJ
Last week, I explored the $880 billion question facing Congress—whether lawmakers could achieve their budget goals without cutting Medicaid. This week, that question took center stage as Dr Mehmet Oz, President Trump's nominee to lead the...
Last week, I explored the $880 billion question facing Congress—whether lawmakers could achieve their budget goals without cutting Medicaid. This week, that question took center stage as Dr Mehmet Oz, President Trump's nominee to lead the...
Last week, I explored the $880...
03/19/2025
First Report Managed Care
Behind the Bill
The $880 Billion Question: Can Congress Cut Spending Without Touching Medicaid?
03/12/2025
Katie Hayes, MJ
I’d like to step away from administrative law for a moment to provide a quick update on Medicaid. With news coming from all sides, what does the future of Medicaid actually look like? The House of Representatives narrowly passed a budget...
I’d like to step away from administrative law for a moment to provide a quick update on Medicaid. With news coming from all sides, what does the future of Medicaid actually look like? The House of Representatives narrowly passed a budget...
I’d like to step away from...
03/12/2025
First Report Managed Care
Behind the Bill
RFK Jr’s Public Comment Ban: The Silent Shift in Health Care Rulemaking
03/05/2025
Katie Hayes, MJ
The erosion of administrative law continues, and with it, the dismantling of decades-long precedent. In June, the Supreme Court overturned a 40-year-old doctrine that allowed federal agencies to interpret their own ambiguous statutes. Later...
The erosion of administrative law continues, and with it, the dismantling of decades-long precedent. In June, the Supreme Court overturned a 40-year-old doctrine that allowed federal agencies to interpret their own ambiguous statutes. Later...
The erosion of administrative...
03/05/2025
First Report Managed Care
Behind the Bill
Prevention Over Pills? The First 2 Weeks of Health Care’s New Direction
02/26/2025
Katie Hayes, MJ
The dust has barely settled from Robert F Kennedy Jr’s confirmation as Secretary of Health and Human Services (HHS), but the changes are already coming fast and furious—a key theme of the Trump Administration’s actions within the last several...
The dust has barely settled from Robert F Kennedy Jr’s confirmation as Secretary of Health and Human Services (HHS), but the changes are already coming fast and furious—a key theme of the Trump Administration’s actions within the last several...
The dust has barely settled from...
02/26/2025
First Report Managed Care
Behind the Bill
The Nondelegation Doctrine: The Next Constitutional Showdown (Part 2)
02/19/2025
Katie Hayes, MJ
Last week, I explored the potential revival of the nondelegation doctrine through Federal Communication Commission v Consumers’ Research. Today, I want to examine what this could mean for health care regulation by considering the parallels...
Last week, I explored the potential revival of the nondelegation doctrine through Federal Communication Commission v Consumers’ Research. Today, I want to examine what this could mean for health care regulation by considering the parallels...
Last week, I explored the...
02/19/2025
First Report Managed Care
Behind the Bill
The Nondelegation Doctrine: The Next Constitutional Showdown (Part 1)
02/12/2025
Katie Hayes, MJ
Just when you thought the dust had settled from the Chevron decision, the Supreme Court is gearing up to hear arguments in Federal Communications Commission v Consumers' Research next month, potentially reviving the long-dormant nondelegation...
Just when you thought the dust had settled from the Chevron decision, the Supreme Court is gearing up to hear arguments in Federal Communications Commission v Consumers' Research next month, potentially reviving the long-dormant nondelegation...
Just when you thought the dust...
02/12/2025
First Report Managed Care
Behind the Bill
No, President Trump Did Not Actually Sign an Executive Order That Would Increase Drug Costs for Beneficiaries
02/05/2025
Katie Hayes, MJ
On inauguration day, President Trump issued an executive order rescinding several Biden-era health care initiatives, including 3 experimental drug pricing models developed by the Center for Medicare and Medicaid Innovation (CMMI). Oh boy did...
On inauguration day, President Trump issued an executive order rescinding several Biden-era health care initiatives, including 3 experimental drug pricing models developed by the Center for Medicare and Medicaid Innovation (CMMI). Oh boy did...
On inauguration day, President...
02/05/2025
First Report Managed Care
Behind the Bill
Robert F. Kennedy Jr’s Confirmation and the Unexpected Turn in the Drug Pricing Debate
01/29/2025
Katie Hayes, MJ
The Plot Thickens in Drug Pricing Drama Just when you thought the drug pricing debate couldn't get more interesting, Robert F. Kennedy Jr adds an unexpected twist. During closed-door Senate meetings, President Trump’s US Department of...
The Plot Thickens in Drug Pricing Drama Just when you thought the drug pricing debate couldn't get more interesting, Robert F. Kennedy Jr adds an unexpected twist. During closed-door Senate meetings, President Trump’s US Department of...
The Plot Thickens in Drug...
01/29/2025
First Report Managed Care

Subscribe and Stay Ahead With Daily Industry Insights

First Report Managed Care Newsletter

Trending Articles

News
Current Understandings of Disease Mechanisms and Therapeutic Approaches in Multiple Sclerosis
10/23/2024
Juliet Gallagher
A comprehensive review of multiple sclerosis causes, forms, and treatments.
A comprehensive review of multiple sclerosis causes, forms, and treatments.
A comprehensive review of...
10/23/2024
First Report Managed Care
News
Monoclonal Antibody Improves Type 2 Inflammation Biomarkers in Children With Asthma
04/21/2023
Jolynn Tumolo
Findings from a phase 3 study suggest two dose regimens of a monoclonal antibody were similarly efficacious for reducing type 2 inflammatory biomarkers in pediatric patients with asthma.
Findings from a phase 3 study suggest two dose regimens of a monoclonal antibody were similarly efficacious for reducing type 2 inflammatory biomarkers in pediatric patients with asthma.
Findings from a phase 3 study...
04/21/2023
First Report Managed Care
News
Survival Disparity Persists Between Black and White Patients With CLL
05/19/2023
Jolynn Tumolo
When compared to White patients, Black patients with chronic lymphocytic leukemia face a persistent survival disadvantage that is not found among other racial minority groups, researchers reported.
When compared to White patients, Black patients with chronic lymphocytic leukemia face a persistent survival disadvantage that is not found among other racial minority groups, researchers reported.
When compared to White patients,...
05/19/2023
First Report Managed Care
News
Therapy Improves Type 2 Asthma Outcomes Regardless of Allergic Status
06/09/2023
Jolynn Tumolo
Researchers found that long-term treatment with dupilumab improved outcomes in patients with moderate-to-severe GINA-based type 2 asthma, regardless of allergic status.
Researchers found that long-term treatment with dupilumab improved outcomes in patients with moderate-to-severe GINA-based type 2 asthma, regardless of allergic status.
Researchers found that long-term...
06/09/2023
First Report Managed Care
News
Measuring RSV Risk Awareness Among Adults With Diabetes
07/07/2023
Julie Gould
Researchers explored knowledge, attitudes, and perceptions of respiratory syncytial virus (RSV) risk among US adults with diabetes to inform health care provider education efforts related to RSV awareness.
Researchers explored knowledge, attitudes, and perceptions of respiratory syncytial virus (RSV) risk among US adults with diabetes to inform health care provider education efforts related to RSV awareness.
Researchers explored knowledge,...
07/07/2023
Pharmacy Learning Network

April 2018 Volume 15 Issue 4

View Issue Archive
Editorial Correspondence

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use